TRV GP V, LLC holds a concentrated book of 3 stocks worth $498.2M as of Q2 2026 (disclosed Aug 10, 2026, a ~41-day 13F lag). This quarter they opened Cargo Therapeutics Inc and trimmed Rapport Therapeutics Inc. Their largest long position is Rapport Therapeutics Inc at 53% of the equity book.
Top-heavy: concentrated book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
100% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices, no cost basis
No buys this quarter.
Other tracked managers holding the same core names as TRV GP V, LLC
| Manager / fund | Shared names | Their $ in those |
|---|---|---|
| FMR LLC | 3 / 3 | $250.7M |
| BlackRock, Inc. | 3 / 3 | $198.9M |
| GOLDMAN SACHS GROUP INC | 3 / 3 | $170.3M |
| VANGUARD CAPITAL MANAGEMENT LLC | 3 / 3 | $113.1M |
| JANUS HENDERSON GROUP PLC | 3 / 3 | $107.0M |
| STATE STREET CORP | 3 / 3 | $85.7M |
| GEODE CAPITAL MANAGEMENT, LLC | 3 / 3 | $81.4M |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3 / 3 | $40.4M |
Ranked by how many of TRV GP V, LLC's top 3 disclosed names each fund also holds: a cross-fund conviction signal from the latest 13F of every tracked manager.
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Rapport Therapeutics, Inc. COM | $261.7M | 6.28M | 52.5% | ▼−12% Reduced · −855K sh | |
| 2 | Septerna, Inc. COM | $208.2M | 6.22M | 41.8% | —Held | |
| 3 | Maze Therapeutics, Inc. COM | $28.4M | 950.8K | 5.7% | —Held |
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1990717/holdings"
Use Arkolith to show TRV GP V, LLC's latest holdings, largest changes, and filing provenance.
As-of date vs the date the SEC received each filing
| Quarter | As of | Filed | Positions | Value | Form |
|---|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | Aug 10, 2026 | 3 | $498.2M | 13F-HR |
| Q1 2026 | Mar 31, 2026 | May 7, 2026 | 3 | $401.0M | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Feb 13, 2026 | 3 | $429.2M | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Nov 13, 2025 | 3 | $353.5M | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Aug 8, 2025 | 4 | $165.7M | 13F-HR |
| Q1 2025 | Mar 31, 2025 | May 9, 2025 | 4 | $125.1M | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Feb 13, 2025 | 3 | $294.0M | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly, filed up to 45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. Price-derived performance is withheld until the price-source policy and freshness gate are green.